Ira Tabas

65.2k total citations · 25 hit papers
278 papers, 46.3k citations indexed

About

Ira Tabas is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Ira Tabas has authored 278 papers receiving a total of 46.3k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Immunology, 109 papers in Molecular Biology and 96 papers in Surgery. Recurrent topics in Ira Tabas's work include Phagocytosis and Immune Regulation (72 papers), Cholesterol and Lipid Metabolism (64 papers) and Atherosclerosis and Cardiovascular Diseases (53 papers). Ira Tabas is often cited by papers focused on Phagocytosis and Immune Regulation (72 papers), Cholesterol and Lipid Metabolism (64 papers) and Atherosclerosis and Cardiovascular Diseases (53 papers). Ira Tabas collaborates with scholars based in United States, Germany and Canada. Ira Tabas's co-authors include Kevin Jon Williams, David Ron, Kathryn J. Moore, Frederick R. Maxfield, Karin Bornfeldt, Stuart Kornfeld, Alan R. Tall, Arif Yurdagul, Tracie A. Seimon and George Kuriakose and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Ira Tabas

273 papers receiving 45.5k citations

Hit Papers

Integrating the mechanism... 1995 2026 2005 2015 2011 2011 1995 2005 2019 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
    2011 2.2k citations Ira Tabas et al. profile →
  2. Macrophages in the Pathogenesis of Atherosclerosis
    2011 2.1k citations Ira Tabas et al. profile →
  3. The Response-to-Retention Hypothesis of Early Atherogenesis
    1995 1.1k citations Ira Tabas et al. profile →
  4. Role of cholesterol and lipid organization in disease
    2005 1.1k citations Ira Tabas et al. profile →
  5. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
    2019 1.1k citations Arif Yurdagul, Ira Tabas et al. profile →
  6. Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis
    2007 1.0k citations Ira Tabas et al. Circulation profile →
  7. Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
    2013 862 citations Ira Tabas et al. profile →
  8. Macrophage death and defective inflammation resolution in atherosclerosis
    2009 861 citations Ira Tabas profile →
  9. Macrophage Phenotype and Function in Different Stages of Atherosclerosis
    2016 838 citations Ira Tabas et al. Circulation Research profile →
  10. Recent insights into the cellular biology of atherosclerosis
    2015 774 citations Ira Tabas et al. profile →
  11. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages
    2003 735 citations George Kuriakose, Ira Tabas et al. profile →
  12. Insulin Resistance, Hyperglycemia, and Atherosclerosis
    2011 678 citations Ira Tabas et al. profile →
  13. Efferocytosis in health and disease
    2019 649 citations Amanda C. Doran, Arif Yurdagul et al. profile →
  14. Inflammation and plaque vulnerability
    2015 599 citations Peter Libby, Ira Tabas et al. profile →
  15. Autophagy Regulates Cholesterol Efflux from Macrophage Foam Cells via Lysosomal Acid Lipase
    2011 590 citations Ira Tabas et al. profile →
  16. Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis
    2005 518 citations Ira Tabas profile →
  17. Macrophage Autophagy Plays a Protective Role in Advanced Atherosclerosis
    2012 513 citations Ira Tabas et al. profile →
  18. Role of ERO1-α–mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress–induced apoptosis
    2009 503 citations Ira Tabas et al. profile →
  19. Monocyte-Macrophages and T Cells in Atherosclerosis
    2017 460 citations Ira Tabas et al. profile →
  20. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
    2020 446 citations Robert F. Schwabe, Ira Tabas et al. profile →
  21. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
    2021 370 citations Maaike Schilperoort, Jinjun Shi et al. profile →
  22. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
    2016 326 citations Gabrielle Fredman, George Kuriakose et al. Nature Communications profile →
  23. Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury
    2020 321 citations Arif Yurdagul, Xiaobo Wang et al. profile →
  24. Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
    2016 313 citations Xiaobo Wang, Ze Zheng et al. profile →
  25. Efferocytosis induces macrophage proliferation to help resolve tissue injury
    2021 209 citations Brennan D. Gerlach, Patrick B. Ampomah et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ira Tabas 20.0k 15.8k 10.9k 10.7k 8.3k 278 46.3k
Alan R. Saltiel 25.3k 1.3× 6.4k 0.4× 5.8k 0.5× 9.4k 0.9× 6.4k 0.8× 280 45.5k
David A. Brenner 20.1k 1.0× 7.1k 0.4× 9.0k 0.8× 26.8k 2.5× 4.5k 0.5× 517 59.5k
Edward A. Fisher 11.6k 0.6× 9.3k 0.6× 9.8k 0.9× 6.3k 0.6× 2.8k 0.3× 433 35.2k
Joseph L. Witztum 18.4k 0.9× 26.5k 1.7× 21.8k 2.0× 10.1k 0.9× 2.4k 0.3× 460 72.1k
Scott L. Friedman 18.1k 0.9× 5.4k 0.3× 9.6k 0.9× 32.5k 3.0× 5.7k 0.7× 438 61.8k
Steven E. Shoelson 17.7k 0.9× 7.9k 0.5× 4.0k 0.4× 9.3k 0.9× 2.6k 0.3× 173 35.9k
Göran K. Hansson 14.0k 0.7× 28.1k 1.8× 9.5k 0.9× 11.5k 1.1× 1.3k 0.2× 455 53.2k
Peter Tontonoz 27.4k 1.4× 7.2k 0.5× 13.3k 1.2× 7.8k 0.7× 1.9k 0.2× 228 45.0k
Seppo Ylä‐Herttuala 21.8k 1.1× 8.3k 0.5× 9.0k 0.8× 3.4k 0.3× 2.0k 0.2× 748 44.5k
Morris F. White 32.8k 1.6× 4.3k 0.3× 12.4k 1.1× 6.5k 0.6× 4.8k 0.6× 346 51.4k

Countries citing papers authored by Ira Tabas

Since Specialization
Citations

This map shows the geographic impact of Ira Tabas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ira Tabas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ira Tabas more than expected).

Fields of papers citing papers by Ira Tabas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ira Tabas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ira Tabas. The network helps show where Ira Tabas may publish in the future.

Co-authorship network of co-authors of Ira Tabas

This figure shows the co-authorship network connecting the top 25 collaborators of Ira Tabas. A scholar is included among the top collaborators of Ira Tabas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ira Tabas. Ira Tabas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Hongxue, Xiaobo Wang, Brennan D. Gerlach, et al.. (2025). Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis. Science Translational Medicine. 17(815). eadv2106–eadv2106. 2 indexed citations
2.
Wu, Xun, Ziyi Wang, Katherine R. Croce, et al.. (2025). Macrophage WDFY3 mitigates autoimmunity by enhancing efferocytosis and suppressing T cell activation in mice. Nature Communications. 16(1). 8694–8694.
3.
Pauli, Jessica, Nadja Sachs, Katja Steiger, et al.. (2025). Single cell spatial transcriptomics integration deciphers the morphological heterogeneity of atherosclerotic carotid arteries. Nature Communications. 16(1). 11282–11282. 1 indexed citations
4.
Ampomah, Patrick B., Lancia Darville, Xiaobo Wang, et al.. (2024). Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution. Nature Metabolism. 6(9). 1736–1755. 31 indexed citations
5.
Liu, Wenli, Mustafa Yalçınkaya, Malgorzata Olszewska, et al.. (2023). Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis. Nature Cardiovascular Research. 2(6). 572–586. 38 indexed citations
6.
Yalçınkaya, Mustafa, Wenli Liu, Malgorzata Olszewska, et al.. (2023). BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis. Circulation. 148(22). 1764–1777. 42 indexed citations
7.
Shi, Hongxue, et al.. (2023). Efferocytosis in liver disease. JHEP Reports. 6(1). 100960–100960. 18 indexed citations
8.
Ampomah, Patrick B., Bishuang Cai, Brennan D. Gerlach, et al.. (2022). Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution. Nature Metabolism. 4(4). 444–457. 98 indexed citations
9.
Shi, Hongxue, Xiaobo Wang, Fang Li, et al.. (2022). CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis. Science Translational Medicine. 14(672). eabp8309–eabp8309. 55 indexed citations
10.
Shi, Jianting, Xun Wu, Ziyi Wang, et al.. (2022). A genome-wide CRISPR screen identifies WDFY3 as a regulator of macrophage efferocytosis. Nature Communications. 13(1). 7929–7929. 26 indexed citations
11.
Yu, Junjie, Changyu Zhu, Xiaobo Wang, et al.. (2021). Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis. Science Translational Medicine. 13(599). 94 indexed citations
12.
Kasikara, Canan, Maaike Schilperoort, Brennan D. Gerlach, et al.. (2021). Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis. Journal of Clinical Investigation. 131(8). 36 indexed citations
13.
Wang, Xiaobo, Hongxue Shi, Changyu Zhu, et al.. (2021). TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis. Journal of Hepatology. 76(4). 910–920. 32 indexed citations
14.
Tao, Wei, Arif Yurdagul, Na Kong, et al.. (2020). siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice. Science Translational Medicine. 12(553). 191 indexed citations
15.
Zheng, Ze, Keiko Nakamura, Xiaobo Wang, et al.. (2020). Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity. Journal of Clinical Investigation. 130(8). 4348–4359. 28 indexed citations
16.
Zhu, Changyu, KyeongJin Kim, Xiaobo Wang, et al.. (2018). Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Science Translational Medicine. 10(468). 194 indexed citations
17.
Zheng, Ze, Lalitha Nayak, Arif Yurdagul, et al.. (2018). An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1. Blood. 133(7). 743–753. 19 indexed citations
18.
Wang, Ying, et al.. (2013). Macrophage Mitochondrial Oxidative Stress Promotes Atherosclerosis and Nuclear Factor-κB–Mediated Inflammation in Macrophages. Circulation Research. 114(3). 421–433. 215 indexed citations
19.
Tabas, Ira. (2002). Cholesterol in health and disease. Journal of Clinical Investigation. 110(5). 583–590. 147 indexed citations
20.
Tabas, Ira. (2002). Cholesterol in health and disease. Journal of Clinical Investigation. 110(5). 583–590. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan R. Saltiel Breakdown of academic impact, for papers by David A. Brenner Breakdown of academic impact, for papers by Edward A. Fisher Breakdown of academic impact, for papers by Joseph L. Witztum Breakdown of academic impact, for papers by Scott L. Friedman Breakdown of academic impact, for papers by Steven E. Shoelson Breakdown of academic impact, for papers by Göran K. Hansson Breakdown of academic impact, for papers by Peter Tontonoz Breakdown of academic impact, for papers by Seppo Ylä‐Herttuala Breakdown of academic impact, for papers by Morris F. White
Rankless by CCL
2026